News

NAAF’s Youngest Legislative Mentor Scores Success

Stephanie Milewski, age 12, signed up to be a Legislative Mentor (a legislative advocate under voting age) this past November….

NAAF Adds Two New Board Members

            NAAF is proud to announce that David Granson and Lisa Bard Levine, MD, MBA,…

Dr. Lindsay Criswell

NIAMS Leadership Meets with NAAF

Key leaders of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) met with NAAF President & CEO,…

Puzzle pieces with medical terms like clincal trial

Alopecia Areata Research Depends on Clinical Trial Volunteers

Media reports of two newly approved drugs for treating alopecia areata brought good news to many people living with the…

researcher looking at a microscope

Zura Bio Joins NAAF’s 2023 Industry Partner Program

NAAF is pleased to announce that Zura Bio has joined the Industry Partner Program at the Bronze membership level. Zura…

Seeking Support for Alopecia Areata? NAAF Can Help

There’s no need to go it alone. NAAF support systems can help. At any given time, about 700,000 people in…

FDA Approves LITFULO™ (Ritlecitinib) for Adults and Children ages 12+ with Severe Alopecia Areata

Today, the U.S. Food and Drug Administration (FDA) approved LITFULO™ for severe alopecia areata, marking the second FDA-approved treatment for…

NAAF Community Member Gets Special Surprise on “The Today Show”

Isoken Igbinedion, Ifueko Igbinedion and Simone Kendle, the founders of Parfait Wigs – a NAAF Conference vendor – appeared on…

New Clinical Trial Data Published for Ritlecitinib

Results from a clinical trial for a new treatment for alopecia areata were published in the medical journal The Lancet…

NAAF Adds Two New Board Members

Shamsha Damani is a seasoned healthcare professional with a strong track record of driving business growth. With over 20 years…